B. Schenk

Increase in antibody-dependent cellular cytotoxicity (ADCC) in a patient with advanced colorectal carcinoma carrying a KRAS mutation under lenalidomide therapy

H. Zwierzina, T. Auer, D. Putzer, 2014, Cancer biology & therapy.

Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and monoclonal antibodies

S. Hoehl, S. Ciesek, M. Widera, 2021, medRxiv.

Aviscumine, a recombinant ribosomal inhibitor, increases the antitumor activity of natural killer cells.

H. Zwierzina, T. Auer, H. Lentzen, 2017, Oncology letters.